RxSight COO awarded 32,218 RSUs

Goldshleger Ilya reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/03/2026 - 08:21 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Goldshleger Ilya reported acquisition or exercise transactions in this Form 4 filing.

RxSight, Inc. reported that Chief Operating Officer Ilya Goldshleger received a grant of 32,218 restricted stock units on February 27, 2026. Each RSU represents a right to one share of common stock. The award vests in six equal installments on trading days on or after August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028, and February 28, 2029, if he continues as a service provider.

Insider Trade Summary

Grant/Award: 32,218 shares

Grant/Award 1 txn

Insider Goldshleger Ilya

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	32,218	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 32,218 contracts (Direct)

Holdings Before and After: Restricted Stock Unit, 0 to 32,218 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2. F2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did RxSight (RXST) report for Ilya Goldshleger?

RxSight reported that Chief Operating Officer Ilya Goldshleger received a grant of 32,218 restricted stock units. These RSUs were awarded on February 27, 2026 and represent a contingent right to receive an equal number of shares of RxSight common stock, subject to time-based vesting.

How many restricted stock units were granted to the RxSight (RXST) COO?

The Chief Operating Officer of RxSight was granted 32,218 restricted stock units. Each RSU corresponds to one share of common stock, giving him a potential future equity stake that vests over multiple years if he continues serving the company as defined in its equity plan.

When do Ilya Goldshleger’s RxSight (RXST) RSUs vest?

The RSUs vest in six equal installments on trading days on or after August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028, and February 28, 2029. Vesting is conditioned on his continued status as a service provider under the equity plan.

What does each RxSight (RXST) restricted stock unit granted to the COO represent?

Each restricted stock unit granted to the COO represents a contingent right to receive one share of RxSight common stock. The rights become actual shares only as units vest over time, assuming he continues to meet the service requirements under the company’s 2021 Equity Incentive Plan.

Is the RxSight (RXST) COO’s RSU award an acquisition or sale of shares?

The transaction is classified as an acquisition through a grant or award of RSUs, not an open-market purchase or sale. It reflects compensation in equity form that may convert into common stock as vesting milestones are reached over the 2026–2029 period.

Does the RxSight (RXST) Form 4 show any insider share sales?

The Form 4 reflects only a grant of 32,218 restricted stock units to the Chief Operating Officer, classified as an acquisition. There are no reported dispositions or sales of shares in this transaction, and the RSUs vest gradually across six specified future dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldshleger Ilya

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CA 92656

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/27/2026		A		32,218		(2)	(2)	Common Stock	32,218	$0	32,218	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029.

Remarks:

Exhibit 24- Power of Attorney

	/s/ Jim Schindler, as Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.